Search Results
Feb 26, 2026, 14:30 ET Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer
Luckenbaugh A. Epidemiology and mortality of metastatic castration-resistant prostate cancer (mCRPC) in a managed care population in the United States. J Clin Oncol. 2020;38(15_suppl):e13592. doi:10.1200/JCO.2020.38.15_suppl.e13592
More news about: Johnson & Johnson
Feb 25, 2026, 11:56 ET Verão fitness: exercícios físicos podem piorar a flacidez da pele; entenda motivos e como tratar
February 2024, Paris, France9. Weiss RA et al. Dermatol Surg. 2016 Jun;42(6):699-709 10. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 11. Talarico S et al. Dermatol Surg. 2015 Dec;41(12):1361-9. 12.
More news about: Galderma
Feb 25, 2026, 07:06 ET Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting
September 2017.6 Price, A. and Svard, U. A Second Decade Lifetable Survival Analysis of the Oxford Unicompartmental Knee Arthroplasty. Clin Orthop Relat Res. 2011 Jan;469(1): 174-9.7 Pandit et al. The clinical outcome of minimally invasive phase 3 Oxford unicompartmental
More news about: Zimmer Biomet Holdings, Inc.
Feb 24, 2026, 16:03 ET Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)
1 Tranekær S, Hansen DL, Frederiksen H. Epidemiology of secondary warm autoimmune haemolytic anaemia-A systematic review and meta-analysis. J Clin Med. 2021 Mar 17;10(6):1244. doi:10.3390/jcm10061244. PMID: 33802848; PMCID: PMC8002719.
More news about: Johnson & Johnson
Feb 24, 2026, 09:30 ET Lung Cancer Research Foundation Launches Small Cell Lung Cancer Grants in Collaboration with AstraZeneca
Cancer Facts & Figures 2024, Atlanta: American Cancer Society; 2024. 2 Megyesfalvi Z, Gay CM, Popper H, et al. CA Cancer J Clin. 2023; 73(6): 620-652. 3 Horn L, Mansfield AS, Szczęsna A, et al. N Engl J Med. 2018; 379(23): 2220-2229.4 Paz-Ares
More news about: Lung Cancer Research Foundation
Feb 22, 2026, 04:51 ET Lenire muestra resultados positivos consistentes para pacientes con tinnitus en Estados Unidos
de al menos 7 puntos en la escala THI para el artículo.11. A. McCombe et al., Directrices para la clasificación de la gravedad del tinnitus, Clin. Otolaryngol. 2001, 26, 388-393.Acerca de Neuromod Fundada en 2010, Neuromod Devices es una empresa global de tecnología médica
More news about: Neuromod Devices
Feb 20, 2026, 17:59 ET Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation
J Clin Psychopharmacol. 2008;28(2 Suppl 1):S4-S11. doi:10.1097/JCP.0b013e3181692787. Cutler AJ, et
More news about: Vanda Pharmaceuticals Inc.
Feb 20, 2026, 12:13 ET O ano começou de verdade! Conheça tratamentos que vão cuidar da sua pele em 2026
1-3 February 2024, Paris, France 9. Weiss RA et al. Dermatol Surg. 2016 Jun;42(6):699-709 10. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 11. Talarico S et al. Dermatol Surg. 2015 Dec;41(12):1361-9. 12.
More news about: Galderma
Feb 20, 2026, 08:00 ET Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
M, Han JY, et al. Clinicopathologic features and response to therapy of NRG1 fusion–driven lung cancers: The eNRGy1 global multicenter registry. J Clin Oncol. 2021;39(25):2791-2802.
More news about: Partner Therapeutics, Inc.
Feb 19, 2026, 09:00 ET Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects
Transplantation, 103(1): p e1-e13, 2019.Ewsome PN and Loomba R. Therapeutic horizons in metabolic dysfunction–associated steatohepatitis. J Clin Invest.135(13):e186425; 2025.GENFIT: Announces Results from Interim Analysis of RESOLVE-IT Phase 3 Trial of Elafibranor in Adults with NASH
More news about: Devonian Health Group Inc.
Feb 17, 2026, 12:54 ET Lenire zeigt durchgängig positive Ergebnisse für Tinnitus-Patienten in den USA in der zweiten Peer-Review-Real-World-Studie
Verbesserung von mindestens 7 Punkten auf der THI-Skala für das Papier.A. McCombe et al., Guidelines for the grading of tinnitus severity, Clin. Otolaryngol. 2001, 26, 388 - 393Über Neuromod Neuromod Devices wurde 2010 gegründet und ist ein globales Medizintechnikunternehmen
More news about: Neuromod Devices
Feb 17, 2026, 05:30 ET Lenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study
defined as at least 7-points of improvement on the THI scale for the paper.A. McCombe et al., Guidelines for the grading of tinnitus severity, Clin. Otolaryngol. 2001, 26, 388 - 393About Neuromod Founded in 2010, Neuromod Devices is a global medical technology company
More news about: Neuromod Devices
Feb 17, 2026, 05:30 ET Lenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study
defined as at least 7-points of improvement on the THI scale for the paper.A. McCombe et al., Guidelines for the grading of tinnitus severity, Clin. Otolaryngol. 2001, 26, 388 - 393About Neuromod Founded in 2010, Neuromod Devices is a global medical technology company
More news about: Neuromod Devices
Feb 17, 2026, 05:30 ET Lenire montre des résultats positifs constants pour les patients américains souffrant d'acouphènes dans une deuxième étude en situation réelle évaluée par des pairs.
comme une amélioration d'au moins 7 points sur l'échelle THI pour l'article.A. McCombe et al, Guidelines for the grading of tinnitus severity, Clin. Otolaryngol. 2001, 26, 388 - 393À propos de Neuromod Créé en 2010, Neuromod Devices est une entreprise internationale de
More news about: Neuromod Devices
Feb 16, 2026, 06:45 ET Lilly's Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer
doi:10.3389/pore.2021.592997Wang R, Hu H, Pan Y, et al. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer. J Clin Oncol 2012;30:4352-4359.Retevmo. Prescribing information. Lilly USA, LLC.Refer to: Kyle Owens;
More news about: Eli Lilly and Company
Feb 13, 2026, 16:53 ET EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA® VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS
Epidemiologie, Pathophysiologie und klinische Manifestationen. J Clin Med. 2021;10(11):2235.Hehir MK, Silvestri NJ. Generalisierte Myasthenia gravis: Klassifizierung, klinische Präsentation, natürlicher Verlauf und Epidemiologie. Neurol Clin. 2018;36:253-260.
More news about: Amgen
Feb 13, 2026, 14:41 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK UPLIZNA® OD SPOLOČNOSTI AMGEN NA LIEČBU GENERALIZOVANEJ MYASTÉNIE GRAVIS
Myasthenia gravis: epidemiológia, patofyziológia a klinické prejavy. J Clin Med. 2021;10(11):2235.Hehir MK, Silvestri NJ. Generalizovaná myasténia gravis: klasifikácia, klinický obraz, prirodzený priebeh a epidemiológia. Neurol Clin. 2018;36:253-260.
More news about: Amgen
Feb 13, 2026, 11:47 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN UPLIZNA ® ДЛЯ ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАННОЙ МИАСТЕНИИ
epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(11):2235.Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018;36:253-260.
More news about: Amgen
Feb 13, 2026, 11:41 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK UPLIZNA® SPOLEČNOSTI AMGEN PRO GENERALIZOVANOU MYASTENII GRAVIS
epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(11):2235.Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018;36:253-260.
More news about: Amgen
Feb 13, 2026, 09:34 ET KOMISJA EUROPEJSKA ZATWIERDZA LEK UPLIZNA® FIRMY AMGEN W LECZENIU UOGÓLNIONEJ MIASTENII
objawy kliniczne). J Clin Med. 2021;10(11):2235.Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology (Uogólniona miastenia: klasyfikacja, obraz kliniczny, naturalny przebieg i epidemiologia). Neurol Clin. 2018;36:253-260.
More news about: Amgen
Feb 13, 2026, 02:00 ET EYE PCR erhält CE-Zeichen für fixOflex Endocapsular Device und ermöglicht damit die europäische Markteinführung
Gu X. Academy IRIS® Registry Analysis of Incidence of Laser Capsulotomy Due to Posterior Capsule Opacification After Intraocular Lens Implantation. Clin Ophthalmol. 2022;16:1721-1730.
More news about: EYE PCR
Feb 13, 2026, 02:00 ET EYE PCR Receives CE Mark for fixOflex Endocapsular Device, Enabling European Market Introduction
Gu X. Academy IRIS® Registry Analysis of Incidence of Laser Capsulotomy Due to Posterior Capsule Opacification After Intraocular Lens Implantation. Clin Ophthalmol. 2022;16:1721-1730.
More news about: EYE PCR
Feb 13, 2026, 02:00 ET EYE PCR recibe el marcado CE para dispositivo endocapsular fixOflex
Academy IRIS® sobre la incidencia de capsulotomía láser debida a opacificación de la cápsula posterior tras la implantación de una lente intraocular. Clin Ophthalmol. 2022;16:1721-1730.
More news about: EYE PCR
Feb 13, 2026, 02:00 ET EYE PCR reçoit le marquage CE pour le dispositif endocapsulaire fixOflex, ce qui permet son introduction sur le marché européen.
Gu X. Academy IRIS® Registry Analysis of Incidence of Laser Capsulotomy Due to Posterior Capsule Opacification After Intraocular Lens Implantation. Clin Ophthalmol. 2022;16:1721-1730.
More news about: EYE PCR
Feb 12, 2026, 16:02 ET Le St. Louis CITY SC dévoile la « tenue Tina Turner ».
spectacles en direct. Sa silhouette apparaît en or métallique sur l'étiquette d'authentification de la tenue, tandis que sa signature, en rouge CITY, est un clin d'œil à son rouge à lèvres et à ses ongles emblématiques.Le partenaire fondateur et le sponsor du maillot, Purina, sont mis en valeur en noir,
More news about: St. Louis City SC